Research Paper Volume 15, Issue 11 pp 4774—4793
Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling
Figure 3. Visfatin promotes increases in VEGF-C expression in ESCC cells. (A–D) ESCC cells were stimulated with visfatin for 24 h, before determining levels of VEGF-C mRNA and protein expression by qPCR (A), Western blot (B, C), and ELISA (D). *P < 0.05 compared with the control group.